Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 3 of 3
Full-Text Articles in Medicine and Health Sciences
The Efficacy And Toxicity Of Bupropion In The Elderly, William T. Howard M.D., M.S., Julia K. Warnock M.D., Ph.D.
The Efficacy And Toxicity Of Bupropion In The Elderly, William T. Howard M.D., M.S., Julia K. Warnock M.D., Ph.D.
Jefferson Journal of Psychiatry
Bupropion is an antidepressant with excellent tolerability and few side effects or drug interactions. These characteristics suite it well for use both in the elderly and in the medically ill. However, early reports of seizures with bupropion therapy in patients with bulimia limited its use. The pharmacology, efficacy, toxicity, and side effect profile of both the immediate release (IR) and the recently available sustained release (SR) formulations of bupropion are reviewed. Bupropion SR is associated with a reduced seizure incidence (0.1%) compared to that found with the IR formulation (0.4%). Recent reports, however, demonstrate that the half-life of bupropion is …
A New Onset Paranoid Psychosis Associated With Fluoxetine And Bupropion: A Case Report, Vassili V. Arkadiev M.D., Stephen L. Ruedrich M.D.
A New Onset Paranoid Psychosis Associated With Fluoxetine And Bupropion: A Case Report, Vassili V. Arkadiev M.D., Stephen L. Ruedrich M.D.
Jefferson Journal of Psychiatry
No abstract provided.
Methylphenidate, Bupropion, And Ssri Triple Therapy, William Bobo M.D.
Methylphenidate, Bupropion, And Ssri Triple Therapy, William Bobo M.D.
Jefferson Journal of Psychiatry
Methylphenidate and bupropion have been demonstrated as being effective adjuncts to serotonin reuptake inhibitors in the treatment of depression (1,2). The use of these medications in case of a depressed patient whose condition was resistant to several forms of monotherapy, monotherapy with "standard" augmentation and ECT. After only a partial response to fluoxetine and methylphenidate, bupropion was added, resulting in full, sustained remission.